Westport, CT, July 17, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Jerry Zeldis, M.D., Ph.D., Chief Medical Officer of ViralClear Pharmaceuticals, Inc. , a majority owned subsidiary of BioSig, will be participating in the B Riley F
July 17, 2020
· 4 min read